Efforts to Control the Errant Products of a Targeted In vivo Generator
- 1 June 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (11) , 4888-4895
- https://doi.org/10.1158/0008-5472.can-04-3096
Abstract
Connexins are gap junction proteins that assemble into channels that mediate direct intercellular communication. Connexins are well-documented tumor suppressors and are thought to regulate both cell growth and differentiation. As previously reported, most human breast tumors and cell lines down-regulate gap junctions or have defective gap junctional intercellular communication. Furthermore, overexpression of connexins in breast cancer cells inhibits tumor growth in vivo. In this study, we hypothesize that controlled Cx43 down-regulation would induce breast tumor cells to acquire a more aggressive phenotype. Here we report that Cx43 was down-regulated in both normal rat kidney (NRK) cells and human breast cancer cell lines (MDA-MB-231 and Hs578T) by transfection with chemically synthesized small interfering RNA (siRNA) or short hairpin RNA generated from a retroviral infection. Furthermore, we show that retroviral delivery and expression of siRNA directed to different coding regions of Cx43 resulted in differential levels of Cx43 silencing and impaired gap junctional intercellular communication. Cx43-silenced Hs578T cells grew faster and were more migratory. Finally, Western blot analysis revealed that down-regulation of Cx43 resulted in decreased expression of thrombospondin-1, an antiangiogenesis molecule, and increased expression of vascular endothelial growth factor. Taken together, these results suggest that Cx43 is required for maintaining cell differentiation and the regulation of molecules important in angiogenesis.Keywords
This publication has 31 references indexed in Scilit:
- Antibody-based treatment of acute myeloid leukaemiaExpert Opinion on Biological Therapy, 2004
- Selective T-cell ablation with bismuth-213–labeled anti-TCRαβ as nonmyeloablative conditioning for allogeneic canine marrow transplantationBlood, 2003
- Ac-225 and her daughters: the many faces of ShivaCell Death & Differentiation, 2002
- Tumor Therapy with Targeted Atomic NanogeneratorsScience, 2001
- Randomized Placebo-Controlled Trial of 2,3-Dimercapto-1-propanesulfonate (DMPS) in Therapy of Chronic Arsenicosis Due to Drinking Arsenic-Contaminated WaterJournal of Toxicology: Clinical Toxicology, 2001
- Comparison of 225actinium chelates: tissue distribution and radiotoxicityNuclear Medicine and Biology, 1999
- Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapyNuclear Medicine and Biology, 1996
- Effectiveness of DTPA Treatments Following the Injection of Particulate PlutoniumInternational Journal of Radiation Biology, 1991
- Antidotes for Acute Bismuth IntoxicationJournal of Toxicology: Clinical Toxicology, 1983
- Anti-lewisite activity and stability of Meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acidLife Sciences, 1982